Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE: Incidence, Course, and Predicting Factors in Patients with Gastroenteropancreatic Neuroendocrine Tumors - Bergsma, H; van Lom, K; Raaijmakers, M (J Nucl Med, 2018)
et al.